StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Amgen (AMGN) PT Lowered to $193 at Morgan Stanley Following 3Q
October 26, 2017 9:25 AM
Morgan Stanley lowered its price target on Amgen (NASDAQ: AMGN) to $193.00 (from $196.00) while maintaining a Overweight rating following ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Next Articles
Amgen (AMGN): Raising PT On Repatha Rebound In 2018 - Oppeneheimer
October 26, 2017 6:43 AM
Amgen (AMGN): Cutting PT On Broad Revenue Miss - BMO
October 26, 2017 6:32 AM
After-Hours Stock Movers 10/25: (BWLD) (TRVN) (SRPT) Higher; (NTRI) (UCTT) (NOW) Lower (more...)
October 25, 2017 5:53 PM
Amgen quarterly profit tops expectations despite sales decline
October 25, 2017 4:12 PM
Amgen (AMGN) Tops Q3 EPS by 23c
October 25, 2017 4:03 PM
Amgen Reports Third Quarter 2017 Financial Results
October 25, 2017 4:01 PM
Teva Pharma (TEVA) Files Lawsuit Versus Eli Lilly (LLY) Related to CGRP Mab - Evercore ISI
October 25, 2017 11:17 AM
Dow, S&P gain but Nasdaq dips as healthcare lags
October 25, 2017 7:41 AM
Amgen (AMGN) Names Wanda Austin to Board
October 24, 2017 4:36 PM
Amgen Announces Appointment Of Wanda M. Austin To Board Of Directors
October 24, 2017 4:35 PM
Amgen (AMGN) Declares $1.15 Quarterly Dividend; 2.6% Yield
October 24, 2017 4:00 PM
Amgen Announces 2017 Fourth Quarter Dividend
October 24, 2017 4:00 PM
Amgen (AMGN)
October 24, 2017 10:41 AM
Award-Winning Journalist And Cancer Survivor Joan Lunden Partners With Amgen To Launch 'At Home With Joan' To Empower Patients Battling Cancer
October 24, 2017 9:00 AM
